Mariia V. Barsuk

Mariia V. Barsuk

Auto-generated profile, based on publicly available information

Mariia V. Barsuk

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
VRVilen V. Rameev
Vilen V. Rameev
LKLidiia V. Kozlovskaya
Lidiia V. Kozlovskaya
ARAnna S. Rameeva
Anna S. Rameeva
ANAlexander Novikov
Alexander Novikov
MBMariia V. Barsuk
Mariia V. Barsuk
КВКозловская Лидия Владимировна
Козловская Лидия Владимировна
Aim. To investigate an influence of the currently changed etiologic structure of AA-amyloidosis on the diagnosis and treatment tactics. Materials and methods. In 110 patients with АА-amyloidosis followed during full disease duration (1 month 29 years) etiology, clinical manyfestations and approaches to diagnose and treatment of AA-amyloidosis were evaluated. With ELISA levels of amyloid precursor acute phase inflammation reactant SAA and neutrophil activity marker S100A12 were measured. Results. Among the most common causes of AA-amyloidosis at the present stage, in addition to RA (40.3%), a significant place is occupied by a group of diseases with a predominantly autoinflammatory mechanism (53.73%). To confirm the autoinflammatory mechanism of the predisposing disease it is recommended to study a highly sensitive parameter serum protein S100A12. An effective marker of the risk of AA-amyloidosis progression, especially in patients with subclinical activity of inflammatory disease, is a high level of production of amyloidogenic protein-a precursor of SAA.

7 July 2024 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
MBMaria V. Barsuk
Maria V. Barsuk
ANAlexander Novikov
Alexander Novikov
TMTamara A. Mikhalina
Tamara A. Mikhalina
VRVilen V. Rameev
Vilen V. Rameev
LLLidia V. Lysenko
Lidia V. Lysenko
This clinical case series presents descriptions of 3 patients with familial Mediterranean fever (FMF) who have atypical manifestations and abnormal inheritance mechanisms in terms of Gregor Mendel's laws. Although molecular genetic testing can help with disease diagnosis, it is not always conclusive. The primary need for genetic testing in atypical cases is to explain the mechanism of inflammation and to select the optimal therapy. These clinical observations demonstrate the changes in the spectrum of phenotypic manifestations of FMF in the context of the widespread introduction of molecular genetic methods.